News und Analysen
EQS-News: KION Group Annual General Meeting provides the setting for key long-term appointments to governing bodies
EQS-News: KION Group Annual General Meeting provides the setting for key long-term appointments to governing bodies
EQS-Adhoc: CTS EVENTIM - Executive Board and Supervisory Board propose payment of a dividend
EQS-Adhoc: CTS EVENTIM - Executive Board and Supervisory Board propose payment of a dividend
![EQS-News: GRENKE AG: S&P lowered ratings for GRENKE AG to “BBB/A-2” – New outlook is “stable”: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBPdz09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--4db50f106cec03dc81a4271045bbc188ee53d7db/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Grenke_Logo.jpg?locale=de)
EQS-News: GRENKE AG: S&P lowered ratings for GRENKE AG to “BBB/A-2” – New outlook is “stable”
EQS-News: GRENKE AG: S&P lowered ratings for GRENKE AG to “BBB/A-2” – New outlook is “stable”
![Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN042Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ae05d9a008178586e36a804ddc8db7301200475e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/5009664_Horizon_Logo_Full-Color_CMYK_M01_-281-29.jpg?locale=de)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: MorphoSys AG invites all eligible holders to offer to sell for cash their convertible bonds due 2025 (ISIN DE000A3H2XW6)
EQS-News: MorphoSys AG invites all eligible holders to offer to sell for cash their convertible bonds due 2025 (ISIN DE000A3H2XW6)
EQS-News: MorphoSys AG invites all eligible holders to offer to sell for cash their convertible bonds due 2025 (ISIN DE000A3H2XW6)
EQS-News: MorphoSys AG invites all eligible holders to offer to sell for cash their convertible bonds due 2025 (ISIN DE000A3H2XW6)
EQS-News: Krones AG: Krones to increase dividend for 2022 by 25% to €1.75 per share
EQS-News: Krones AG: Krones to increase dividend for 2022 by 25% to €1.75 per share
EQS-News: CTS EVENTIM continues to grow and posts record results for 2022
EQS-News: CTS EVENTIM continues to grow and posts record results for 2022
EQS-News: Nemetschek SE lays decisive foundations for future dynamic growth after successful 2022 financial year
EQS-News: Nemetschek SE lays decisive foundations for future dynamic growth after successful 2022 financial year
EQS-News: Nemetschek SE lays decisive foundations for future dynamic growth after successful 2022 financial year
EQS-News: Nemetschek SE lays decisive foundations for future dynamic growth after successful 2022 financial year
EQS-News: PATRIZIA Annual Report 2022: Solid operating performance, successful transformation and fifth dividend increase in a row
EQS-News: PATRIZIA Annual Report 2022: Solid operating performance, successful transformation and fifth dividend increase in a row
![Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN042Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ae05d9a008178586e36a804ddc8db7301200475e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/5009664_Horizon_Logo_Full-Color_CMYK_M01_-281-29.jpg?locale=de)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-Adhoc: VARTA AG: VARTA AG successfully completes capital increase with gross proceeds of approximately 51 million euros
EQS-Adhoc: VARTA AG: VARTA AG successfully completes capital increase with gross proceeds of approximately 51 million euros
EQS-Adhoc: VARTA AG: VARTA AG successfully completes capital increase with gross proceeds of approximately 51 million euros
EQS-Adhoc: VARTA AG: VARTA AG successfully completes capital increase with gross proceeds of approximately 51 million euros
![PulteGroup Breaks Ground on Mortgage-Free Home for U.S. Army Veteran in Southwest Florida: https://mms.businesswire.com/media/20230321005212/en/1742745/5/20230203-DSC_5599_web.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM25iYWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0cb5f9e8442ef0a09c986e2b47d0d10056860d40/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/20230203-DSC_5599_web.jpg?locale=de)
PulteGroup Breaks Ground on Mortgage-Free Home for U.S. Army Veteran in Southwest Florida
In its 10th year of providing mortgage-free homes to deserving veterans, national homebuilder PulteGroup has broken ground on a new home for U.S. Army Sergeant First Class Lucio Gaytan. Awarded
![EQS-News: Evotec SE to announce preliminary financial results for fiscal year 2022 on 28 March 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBMUT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--5ccaaee20e4dd47dccd2b888e74ce998199f16f5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Evotec_high_res_logo_-28blue_and_grey-29.jpg?locale=de)
EQS-News: Evotec SE to announce preliminary financial results for fiscal year 2022 on 28 March 2023
EQS-News: Evotec SE to announce preliminary financial results for fiscal year 2022 on 28 March 2023
![Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN042Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ae05d9a008178586e36a804ddc8db7301200475e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/5009664_Horizon_Logo_Full-Color_CMYK_M01_-281-29.jpg?locale=de)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
CTS EVENTIM, MAMMOTH, INC. and AG ENTERTAINMENT TOURING to partner for major U.S. and global tours
CTS EVENTIM, MAMMOTH, INC. and AG ENTERTAINMENT TOURING to partner for major U.S. and global tours
![EQS-News: HELLA GmbH & Co. KGaA: Short fiscal year 2022: HELLA once again achieves record level with order intake of €1 billion per month: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23717/225px-HELLA_Logo_3D_Background_4C_300dpi.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBbUlEIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--701ec538d9b30d9875df935d2d9b201641f5a2b2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/225px-HELLA_Logo_3D_Background_4C_300dpi.jpg?locale=de)
EQS-News: HELLA GmbH & Co. KGaA: Short fiscal year 2022: HELLA once again achieves record level with order intake of €1 billion per month
EQS-News: HELLA GmbH & Co. KGaA: Short fiscal year 2022: HELLA once again achieves record level with order intake of €1 billion per month
![Power Integrations Launches 900 V GaN Flyback Switcher ICs: https://mms.businesswire.com/media/20230320005176/en/1741912/5/InnoSwitch3-EP-900V-PR-2400x1260-031423.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOGphYWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6d077c81c151c7b02d307d28d8aee2bc18742310/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/InnoSwitch3-EP-900V-PR-2400x1260-031423.jpg?locale=de)
Power Integrations Launches 900 V GaN Flyback Switcher ICs
APEC 2023 – Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits (ICs) for energy-efficient power conversion, today announced a 900-volt gallium-nitride (GaN) extension
![Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN042Vmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ae05d9a008178586e36a804ddc8db7301200475e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/5009664_Horizon_Logo_Full-Color_CMYK_M01_-281-29.jpg?locale=de)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: PATRIZIA SE: PATRIZIA’s European Infrastructure Fund II surpasses EUR 800 million in committed investments with double fibre deal in Spain
EQS-News: PATRIZIA SE: PATRIZIA’s European Infrastructure Fund II surpasses EUR 800 million in committed investments with double fibre deal in Spain
EQS-News: VARTA AG: VARTA AG plans capital increase and comprehensive restructuring concept
EQS-News: VARTA AG: VARTA AG plans capital increase and comprehensive restructuring concept
EQS-News: VARTA AG: VARTA AG plans capital increase and comprehensive restructuring concept
EQS-News: VARTA AG: VARTA AG plans capital increase and comprehensive restructuring concept
EQS-Adhoc: VARTA AG: VARTA AG decides to implement a capital increase and is in advanced talks with banks and majority owner about restructuring measures and to secure financing
EQS-Adhoc: VARTA AG: VARTA AG decides to implement a capital increase and is in advanced talks with banks and majority owner about restructuring measures and to secure financing